The Lumipulse test is meant to be part of an evaluation for Alzheimer's disease, including physical and medical history and imaging scans of the brain. The accuracy rate is different between Lumipulse and other blood tests used to help diagnose Alzheimer's disease.
Alzheimer’s disease is diagnosed with multiple types of tests that also help to rule out other possible conditions with similar symptoms. You may have blood and urine tests, memory function tests, and ...
Die Schweizer Pharmafirma Roche hat grünes Licht für einen neuen Bluttest zur Alzheimer-Diagnose bekommen. Er macht aufwendige Untersuchungen obsolet. Das Schweizer Pharmaunternehmen Roche hat grünes ...
Ein einfacher Bluttest könnte die Diagnose von Alzheimer in Zukunft deutlich erleichtern. Er misst zwei Eiweiße im Blut, die mit den typischen Ablagerungen im Gehirn in Verbindung stehen. Statt teurer ...
La enfermedad de Alzheimer es la causa más común de demencia. La enfermedad de Alzheimer es el proceso biológico que comienza con la aparición en el cerebro de una acumulación de proteínas en forma de placas amiloides y ovillos neurofibrilares. Esto hace que las neuronas cerebrales mueran con el tiempo y el cerebro se encoja.
Overview Alzheimer's disease is the most common cause of dementia. Alzheimer's disease is the biological process that begins with the appearance of a buildup of proteins in the form of amyloid plaques and neurofibrillary tangles in the brain. This causes brain cells to die over time and the brain to shrink.
Overview Lewy body dementia, also known as LBD, is the second most common type of dementia after Alzheimer's disease. Protein deposits called Lewy bodies develop in nerve cells in the brain. The protein deposits affect brain regions involved in thinking, memory and movement. There are two forms of LBD that cause cognitive symptoms — dementia with Lewy bodies and Parkinson's disease dementia.